Author:
Tuffaha Muin S. A.,Guski Hans,Kristiansen Glen
Publisher
Springer International Publishing
Reference19 articles.
1. Botti G, Marra L, Anniciello A, et al. Immune-phenotypical markers for the differential diagnosis of melanocytic lesions. Int J Clin Exp Pathol. 2015;8(9):9742–51.
2. Karamchandani JR, Nielsen TO, van de Rijn M, West RB. Sox10 and S100 in the diagnosis of soft-tissue neoplasms. Appl Immunohistochem Mol Morphol. 2012;20(5):445–50.
3. Willis BC, Johnson G, Wang J, et al. SOX10: a useful marker for identifying metastatic melanoma in sentinel lymph nodes. Appl Immunohistochem Mol Morphol. 2015;23(2):109–12.
4. Cimino-Mathews A, Subhauwong AP, Elwood H, et al. Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas. Hum Pathol. 2013;44(6):959–65.
5. Miettinen M, McCue PA, Sarlomo-Rikala M. Sox10—a marker for not only Schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue. Am J Surg Pathol. 2015;39:826–35.